Dynamic Technology Lab Private Ltd acquired a new stake in Alcentra Capital Corp (NASDAQ:ABDC) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 11,452 shares of the asset manager’s stock, valued at approximately $123,000. Dynamic Technology Lab Private Ltd owned about 0.08% of Alcentra Capital as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. Muzinich & Co. Inc. boosted its stake in shares of Alcentra Capital by 34.7% in the 2nd quarter. Muzinich & Co. Inc. now owns 610,164 shares of the asset manager’s stock valued at $8,292,000 after purchasing an additional 157,251 shares during the last quarter. Raymond James Financial Services Advisors Inc. boosted its stake in shares of Alcentra Capital by 45.6% in the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 242,865 shares of the asset manager’s stock valued at $3,300,000 after purchasing an additional 76,115 shares during the last quarter. Goldman Sachs Group Inc. bought a new stake in shares of Alcentra Capital in the 2nd quarter valued at $219,000. Carnegie Capital Asset Management LLC boosted its stake in shares of Alcentra Capital by 8.1% in the 2nd quarter. Carnegie Capital Asset Management LLC now owns 20,011 shares of the asset manager’s stock valued at $232,000 after purchasing an additional 1,500 shares during the last quarter. Finally, Commerce Bank bought a new stake in shares of Alcentra Capital in the 3rd quarter valued at $159,000. 32.06% of the stock is currently owned by institutional investors.

Alcentra Capital Corp (NASDAQ ABDC) opened at $8.34 on Friday. Alcentra Capital Corp has a 1 year low of $7.00 and a 1 year high of $14.73. The stock has a market cap of $118.09, a price-to-earnings ratio of 5.56 and a beta of 0.62.

Alcentra Capital (NASDAQ:ABDC) last released its earnings results on Monday, November 6th. The asset manager reported $0.34 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.33 by $0.01. Alcentra Capital had a negative net margin of 2.25% and a positive return on equity of 11.32%. The company had revenue of $7.61 million for the quarter. equities research analysts expect that Alcentra Capital Corp will post 1.29 earnings per share for the current year.

Alcentra Capital declared that its board has initiated a share buyback plan on Monday, November 6th that authorizes the company to buyback $2.50 million in outstanding shares. This buyback authorization authorizes the asset manager to buy shares of its stock through open market purchases. Stock buyback plans are often a sign that the company’s leadership believes its shares are undervalued.

The business also recently announced a quarterly dividend, which will be paid on Thursday, January 4th. Investors of record on Friday, December 29th will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.99%. Alcentra Capital’s payout ratio is presently -2,719.46%.

In related news, Director Steven H. Reiff bought 6,900 shares of the company’s stock in a transaction that occurred on Monday, November 13th. The shares were bought at an average price of $7.23 per share, for a total transaction of $49,887.00. Following the transaction, the director now directly owns 35,246 shares of the company’s stock, valued at $254,828.58. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Paul J. Echausse sold 10,000 shares of the business’s stock in a transaction on Thursday, November 9th. The shares were sold at an average price of $7.45, for a total transaction of $74,500.00. Following the transaction, the director now owns 58,946 shares in the company, valued at approximately $439,147.70. The disclosure for this sale can be found here. Insiders have purchased a total of 11,730 shares of company stock worth $83,956 in the last quarter. 4.96% of the stock is owned by corporate insiders.

A number of equities research analysts have recently commented on the stock. ValuEngine raised shares of Alcentra Capital from a “buy” rating to a “strong-buy” rating in a research note on Friday, December 1st. Keefe, Bruyette & Woods reaffirmed a “hold” rating and issued a $9.50 price objective on shares of Alcentra Capital in a research note on Friday, November 10th. Raymond James Financial lowered shares of Alcentra Capital from an “outperform” rating to an “underperform” rating in a research note on Wednesday, November 8th. Rowe lowered shares of Alcentra Capital from an “outperform” rating to an “underperform” rating in a research note on Wednesday, November 8th. Finally, UBS lowered shares of Alcentra Capital from an “outperform” rating to an “underperform” rating in a research note on Wednesday, November 8th. Three research analysts have rated the stock with a sell rating, one has issued a hold rating, one has issued a buy rating and one has issued a strong buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $12.83.

TRADEMARK VIOLATION WARNING: “Dynamic Technology Lab Private Ltd Takes Position in Alcentra Capital Corp (ABDC)” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this story can be read at https://www.thecerbatgem.com/2017/12/10/dynamic-technology-lab-private-ltd-takes-position-in-alcentra-capital-corp-abdc.html.

About Alcentra Capital

Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.

Want to see what other hedge funds are holding ABDC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alcentra Capital Corp (NASDAQ:ABDC).

Institutional Ownership by Quarter for Alcentra Capital (NASDAQ:ABDC)

Receive News & Stock Ratings for Alcentra Capital Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital Corp and related stocks with our FREE daily email newsletter.